• Hong Kong Science and Technology Parks Corporation (HKSTPC) and WuXi XDC signed a cooperation framework agreement to jointly promote the establishment of a contract research, development and manufacturing organization(CRDMO) value chain in Hong Kong.
• HKSTP Park companies will leverage WuXi XDC's one-stop service platform to develop ADC and other bioconjugates.
• WuXi XDC will support the development of the bioconjugation industry in Hong Kong by providing consultation and training to local enterprises.

The partnership will drive the development of ADC and other bioconjugates in Hong Kong leveraging WuXi XDC's comprehensive services and capabilities. With the aim of boosting the biotechnology ecosystem in Hong Kong, both parties will enhance collaborations among industry, academic and research institutions.

HKSTP Park companies will have access to WuXi XDC's integrated, one-stop bioconjugate platform for drug discovery, development, and analytical services. WuXi XDC will provide consultation and training to Hong Kong biotechnology companies and research institutions, accelerating the translation of the scientific research results into market-ready products.

HKSTPC and WuXi XDC will deepen the collaborations by sharing resources and organizing engagement activities. A roadmap will be set out for propelling the establishment of a CRDMO value chain in Hong Kong, which will in turn speed up the drug development process and shorten the time to market.

Dr. Jimmy Li, CEO of WuXi XDC, said, "We are pleased to collaborate with HKSTP in supporting local biotech companies with our one-stop platform, leading industry know-how and high-quality services. Hong Kong Science Park is a hotbed for biotechnology with innovation capabilities. We look forward to cementing our partnership with HKSTP, enabling the development of the bioconjugate industry and benefiting patients worldwide."

Mr. Albert Wong, CEO of HKSTP, said, "As the largest technology research and development (R&D) base and incubator in Hong Kong, HKSTPC offers integrated state-of-the-art infrastructure and supporting services to the I&T ecosystem. We are excited to work with WuXi XDC to facilitate companies in terms of technology transfer and market expansion. By leveraging the strengths of both sides, we look forward to further enhancing the biotechnology ecosystem, paving the way for Hong Kong's development into an international innovation and technology hub."